Nabilah Ahmad Kamal

QIMR Berghofer Medical Research Institute — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

1h-index39citations13works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(9), Cancer, Hypoxia, and Metabolism(4), Melanoma and MAPK Pathways(4), Protein Degradation and Inhibitors(4), Chemical Reactions and Isotopes(4)

Publications13 total

Data from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
2023Open Access
Supplementary Figures from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
2023Open Access
Data from Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis
2023Open Access
Supplementary Data from Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis
2023Open Access
Supplementary Tables from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
2023Open Access
Data from Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis
2023Open Access
Supplementary Data from Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis
2023Open Access
Data from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
2023Open Access
Supplementary Figures from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
2023Open Access
Supplementary Tables from G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
2023Open Access
Supplementary Data from Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis
2023Open Access
Supplementary Data from Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis
2023Open Access
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
Clinical Cancer Research·2021· 39 citedOpen Access

Frequent Co-authors

Greg Kelly(13), Francesco Casciello(13), Nicholas K. Hayward(13), Frank Gannon(13), Jason S. Lee(13), Fares Al‐Ejeh(7), Robert McCuaig(7), Blake Ferguson(7), Antonia L. Pritchard(7), James S. Wilmott(7), Georgina V. Long(7), Richard A. Scolyer(7), Sudha Rao(7), Sayed Ali(6), Ines P. Silva(6), Priya Ramarao-Milne(6), Teneale A. Stewart(6), Pamela Mukhopadhyay(6), Stephen H. Kazakoff(6), Mariska Miranda(6)